Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Single-cell RNA sequencing in pancreatic cancer

The application of single-cell RNA sequencing platforms has generated notable insights into the heterogeneity underlying pancreatic ductal adenocarcinoma (PDAC), encompassing both the neoplastic compartment and the tumour microenvironment. In this Comment, we discuss the most pertinent findings gleaned from both mouse models and human PDAC samples, as well as future opportunities.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Elyada, E. et al. Cross-species single-sell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102–1123 (2019).

    CAS  Article  Google Scholar 

  2. 2.

    Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 29, 725–738 (2019).

    CAS  Article  Google Scholar 

  3. 3.

    Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat. Cancer 1, 1097–1112 (2020).

    Article  Google Scholar 

  4. 4.

    Raghavan, S. et al. The tumor microenvironment drives transcriptional phenotypes and their plasticity in metastatic pancreatic cancer. Preprint at bioRxiv (2021).

  5. 5.

    Zhou, D. C. et al. Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Preprint at bioRxiv (2021).

  6. 6.

    Lee, J. J. et al. Elucidation of tumor-stromal heterogeneity and the ligand-receptor interactome by single cell transcriptomics in real-world pancreatic cancer biopsies. Preprint at bioRxiv (2020).

  7. 7.

    Bernard, V. et al. Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression. Clin. Cancer Res. 25, 2194–2205 (2019).

    CAS  Article  Google Scholar 

  8. 8.

    Hosein, A. N. et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight 5, (2019).

  9. 9.

    Schlesinger, Y. et al. Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells’ heterogeneity. Nat. Commun. 11, 4516 (2020).

    CAS  Article  Google Scholar 

  10. 10.

    Hwang, W. L. et al. Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment. Preprint at bioRxiv (2020).

Download references


P01CA117969 (A.M. and R.A.D.), P50CA221707 (A.M. and R.A.D.), R01CA218004 (A.M.), R01CA220236 (A.M.), MD Anderson Cancer Moonshot program (A.M. and R.A.D.).

Author information



Corresponding author

Correspondence to Anirban Maitra.

Ethics declarations

Competing interests

A.M. receives royalties for a pancreatic cancer biomarker test from Cosmos Wisdom Biotechnology, and is listed as an inventor on a patent that has been licensed by Johns Hopkins University to ThriveEarlier Detection. R.A.D. is Founder and Advisor of Tvardi Therapeutics, Asylia Therapeutics, Stellanova Therapeutics, Nirogy Therapeutics and Sporos Bioventures.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Han, J., DePinho, R.A. & Maitra, A. Single-cell RNA sequencing in pancreatic cancer. Nat Rev Gastroenterol Hepatol 18, 451–452 (2021).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing